Lifecore Biomedical to Participate in the Stephens Annual Investment Conference on Thursday, November 17, 2022
10 11월 2022 - 10:00PM
Landec Corporation (Nasdaq: LNDC) (“Lifecore” or the “Company”), a
diversified health and wellness company with two operating
businesses, Lifecore Biomedical, Inc. (“Lifecore”) and Curation
Foods, Inc. (“Curation Foods”), – today announced that Jim Hall,
CEO of Landec Corporation & President of Lifecore, and John
Morberg, CFO will be hosting a fireside chat at the Stephens Annual
Investment Conference in Nashville, TN.
The Company will participate in a fireside chat
on Thursday, November 17th at 8:00 AM CT. The live audio webcast
will be available to all interested parties through a live audio
webcast accessible on the Company's investor relations website at
https://ir.landec.com/.
About Lifecore
BiomedicalLifecore Biomedical (Nasdaq: LNDC) is a fully
integrated contract development and manufacturing organization
(CDMO) that offers highly differentiated capabilities in the
development, fill and finish of complex sterile injectable
pharmaceutical products in syringes and vials. As a leading
manufacturer of premium, injectable grade Hyaluronic Acid, Lifecore
brings 40 years of expertise as a partner for global and emerging
biopharmaceutical and biotechnology companies across multiple
therapeutic categories to bring their innovations to market. For
more information about the Company, visit Lifecore’s website at
www.lifecore.com.
Landec Corp. Contact
Information:Investor RelationsJeff
Sonnek(646) 277-1263jeff.sonnek@icrinc.com
Landec (NASDAQ:LNDC)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025
Landec (NASDAQ:LNDC)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025
Landec Corp (나스닥)의 실시간 뉴스: 최근 기사 0
More News Articles